End-of-day quote
Shanghai S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
45.06
CNY
|
-0.53%
|
|
-0.86%
|
+12.54%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
27,745
|
47,897
|
39,611
|
46,074
|
40,464
|
45,537
|
-
|
-
|
Enterprise Value (EV)
1 |
27,132
|
46,953
|
37,992
|
43,468
|
38,490
|
42,301
|
39,589
|
40,351
|
P/E ratio
|
50.8
x
|
62
x
|
44.4
x
|
36.3
x
|
28.6
x
|
25.7
x
|
21
x
|
16.8
x
|
Yield
|
0.41%
|
0.33%
|
0.54%
|
0.63%
|
1.25%
|
1.16%
|
1.42%
|
1.83%
|
Capitalization / Revenue
|
2.7
x
|
3.64
x
|
2.58
x
|
2.32
x
|
1.79
x
|
1.66
x
|
1.36
x
|
1.11
x
|
EV / Revenue
|
2.64
x
|
3.57
x
|
2.48
x
|
2.19
x
|
1.7
x
|
1.54
x
|
1.18
x
|
0.99
x
|
EV / EBITDA
|
27
x
|
34.1
x
|
23.7
x
|
19.6
x
|
15.7
x
|
12.8
x
|
10
x
|
8.05
x
|
EV / FCF
|
53
x
|
-
|
-
|
-
|
9.87
x
|
23.2
x
|
12.6
x
|
9.73
x
|
FCF Yield
|
1.89%
|
-
|
-
|
-
|
10.1%
|
4.32%
|
7.91%
|
10.3%
|
Price to Book
|
6.15
x
|
9.13
x
|
5.29
x
|
5.38
x
|
4.13
x
|
4.06
x
|
3.53
x
|
3.09
x
|
Nbr of stocks (in thousands)
|
965,495
|
966,544
|
1,006,271
|
1,010,387
|
1,010,580
|
1,010,580
|
-
|
-
|
Reference price
2 |
28.74
|
49.55
|
39.36
|
45.60
|
40.04
|
45.06
|
45.06
|
45.06
|
Announcement Date
|
4/8/20
|
4/27/21
|
4/28/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,276
|
13,145
|
15,326
|
19,886
|
22,588
|
27,381
|
33,473
|
40,862
|
EBITDA
1 |
1,006
|
1,379
|
1,600
|
2,218
|
2,456
|
3,314
|
3,953
|
5,014
|
EBIT
1 |
815.5
|
1,170
|
1,339
|
1,886
|
2,055
|
2,623
|
3,202
|
3,959
|
Operating Margin
|
7.94%
|
8.9%
|
8.74%
|
9.48%
|
9.1%
|
9.58%
|
9.56%
|
9.69%
|
Earnings before Tax (EBT)
1 |
814.3
|
1,164
|
1,338
|
1,877
|
2,038
|
2,601
|
3,180
|
3,938
|
Net income
1 |
543.8
|
768.3
|
887.9
|
1,266
|
1,412
|
1,775
|
2,170
|
2,705
|
Net margin
|
5.29%
|
5.84%
|
5.79%
|
6.36%
|
6.25%
|
6.48%
|
6.48%
|
6.62%
|
EPS
2 |
0.5659
|
0.7994
|
0.8857
|
1.257
|
1.400
|
1.757
|
2.146
|
2.680
|
Free Cash Flow
1 |
511.4
|
-
|
-
|
-
|
3,900
|
1,827
|
3,130
|
4,148
|
FCF margin
|
4.98%
|
-
|
-
|
-
|
17.26%
|
6.67%
|
9.35%
|
10.15%
|
FCF Conversion (EBITDA)
|
50.84%
|
-
|
-
|
-
|
158.76%
|
55.13%
|
79.18%
|
82.72%
|
FCF Conversion (Net income)
|
94.06%
|
-
|
-
|
-
|
276.18%
|
102.91%
|
144.24%
|
153.34%
|
Dividend per Share
2 |
0.1177
|
0.1648
|
0.2143
|
0.2857
|
0.5000
|
0.5232
|
0.6404
|
0.8264
|
Announcement Date
|
4/8/20
|
4/27/21
|
4/28/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,388
|
4,148
|
4,602
|
4,598
|
6,539
|
5,266
|
5,441
|
-
|
5,181
|
6,700
|
5,971
|
6,574
|
6,421
|
7,915
|
7,768
|
8,023
|
EBITDA
1 |
299.4
|
481.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,140
|
1,127
|
1,180
|
1,241
|
1,306
|
EBIT
1 |
307.2
|
407.3
|
443.1
|
366.9
|
668.2
|
501.7
|
531.1
|
-
|
436.1
|
586
|
593.5
|
671.6
|
595.4
|
648.1
|
748.9
|
817.8
|
Operating Margin
|
7%
|
9.82%
|
9.63%
|
7.98%
|
10.22%
|
9.53%
|
9.76%
|
-
|
8.42%
|
8.75%
|
9.94%
|
10.22%
|
9.27%
|
8.19%
|
9.64%
|
10.19%
|
Earnings before Tax (EBT)
1 |
306.2
|
407.3
|
446
|
366.5
|
657.8
|
500.8
|
530.9
|
1,032
|
436.1
|
569.8
|
593.2
|
645.9
|
633
|
711.5
|
763.5
|
829.9
|
Net income
1 |
191.9
|
272.2
|
304.2
|
247.2
|
442
|
336.5
|
368.7
|
705.2
|
294
|
412.8
|
406.8
|
447.6
|
438.6
|
497.4
|
529.1
|
575.1
|
Net margin
|
4.37%
|
6.56%
|
6.61%
|
5.38%
|
6.76%
|
6.39%
|
6.78%
|
-
|
5.67%
|
6.16%
|
6.81%
|
6.81%
|
6.83%
|
6.28%
|
6.81%
|
7.17%
|
EPS
2 |
0.1929
|
0.2714
|
0.3000
|
0.2429
|
0.4429
|
0.3357
|
0.3643
|
-
|
0.2900
|
0.4100
|
0.4000
|
0.4365
|
0.3970
|
0.4961
|
0.5018
|
0.5691
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5000
|
-
|
-
|
-
|
0.6340
|
Announcement Date
|
4/28/22
|
4/28/22
|
8/29/22
|
10/28/22
|
4/27/23
|
4/27/23
|
8/29/23
|
8/29/23
|
10/30/23
|
4/28/24
|
4/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
613
|
945
|
1,619
|
2,606
|
1,974
|
3,236
|
5,948
|
5,186
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
511
|
-
|
-
|
-
|
3,900
|
1,827
|
3,130
|
4,148
|
ROE (net income / shareholders' equity)
|
12.7%
|
15.5%
|
13%
|
15.8%
|
15.4%
|
16.3%
|
17.5%
|
18.8%
|
ROA (Net income/ Total Assets)
|
6.38%
|
6.95%
|
5.48%
|
-
|
-
|
7.23%
|
7.61%
|
8.1%
|
Assets
1 |
8,521
|
11,062
|
16,190
|
-
|
-
|
24,568
|
28,519
|
33,414
|
Book Value Per Share
2 |
4.670
|
5.430
|
7.430
|
8.470
|
9.700
|
11.10
|
12.70
|
14.60
|
Cash Flow per Share
2 |
1.000
|
1.380
|
2.140
|
3.880
|
4.580
|
3.110
|
3.590
|
4.600
|
Capex
1 |
452
|
579
|
821
|
578
|
724
|
1,242
|
1,230
|
767
|
Capex / Sales
|
4.4%
|
4.4%
|
5.36%
|
2.91%
|
3.21%
|
4.53%
|
3.67%
|
1.88%
|
Announcement Date
|
4/8/20
|
4/27/21
|
4/28/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Last Close Price
45.06
CNY Average target price
53.64
CNY Spread / Average Target +19.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.54% | 6.29B | | -37.88% | 13.99B | | -33.12% | 10.67B | | -11.17% | 5.88B | | +75.00% | 4.93B | | -4.38% | 4.54B | | -9.20% | 3.74B | | -19.40% | 3.16B | | -12.15% | 2.85B | | -12.99% | 2.53B |
Other Drug Retailers
|